leisure time -WSS

leisure time

author：explore 2025-09-06 03:39:46 - browse：57916

Stock illustration of computer and medication — Adobe

Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and mental health counseling.

PursueCare today announced it had raised a $20 million Series B round and that it had acquired Pear’s portfolio of apps that treat people with addiction problems. PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers.

“My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said. “You need a willing and capable service provider that says we’re going to make this a big part of real world care and… then show the health plans how it can save them money in the real world without extra thinking.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

leisure time

hotspot

WSS

A new drug could help frostbite victims avoid its ravages

Measles policy set amid Florida outbreak alarms vaccine proponents

MD Anderson's Padmanee Sharma responds to research credit suit

New CMS data security rules will hurt Medicare, Medicaid research

Can sheer will power keep patients alive in their dying hours?

A new drug could help frostbite victims avoid its ravages

focus

leisure time

knowledge

Bright Health sells Medicare Advantage business to Molina

In 'major milestone,' FDA approves first cell therapy for solid tumors

State Dept. review finds Biden bears some blame for Afghanistan failures

New study raises questions about niacin and heart health

Dobbs anniversary: the lost opportunity of abortion as health care

As AI regulations shape up, health tech startups beg for clarity

Duchenne breakthrough therapy leaves behind pioneering families

Ukraine seeks to reclaim its role as a hub for clinical trials

Supreme Court strikes down use of affirmative action

Drinking less cuts risk of oral cavity, esophageal cancer: Report

hotspot

Medicare Advantage beneficiaries sue Humana over algorithm use

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Medicare Advantage beneficiaries sue Humana over algorithm use

What STAT readers think about the FDA and patient advocacy

Prime Medicine, Myeloid Therapeutics clash over genome

Albert Bourla of Pfizer: worst biopharma CEO of 2023

leisure time

hotspot

explore

Wikipedia